EUVIMEDOpdag EUVIMED
Crossref

Asiatic Acid Alleviates Ulcerative Colitis Through a Gut Microbiota‐Driven cAMP / PKA / NF ‐ κB Pathway: γ‐Glutamyltyrosine Is a Crucial Player

Xian Zheng, Yuanyue Jiang, Wenbo Wang, Kekang Sun, Libin Zhou, Yanru Zhang, Jie Cui, Haiyan Yu, Wenbin Dong, Baofei Yan iD

Phytotherapy Research · 2026-01 · 40 (1) · 267-285

DOI: 10.1002/ptr.70132 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2025-11-24. Written by Xian Zheng and 9 co-authors. Institution: Department of Pharmacy, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, China. Major MEDLINE topics: Gastrointestinal Microbiome, Colitis, Ulcerative, Pentacyclic Triterpenes, Tyrosine. Cited 4 times so far (Crossref); 47 references. Funded by: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Clinical Pharmaceutical Research Foundation of Jiangsu Hengrui Medicine.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Ulcerative colitis (UC) is a chronic inflammatory disease of the colon, characterized by recurrent flare‐ups and limited effectiveness of available drug therapies. Asiatic acid (AA), a triterpenoid compound extracted from Centella asiatica , has shown promising pharmacological activities and therapeutic potential in several inflammation‐related diseases. However, AA's efficacy in treating UC and its precise mechanisms of action remain to be fully explored. This study aimed to provide a comprehensive assessment of AA's therapeutic effects on UC and to investigate its underlying mechanisms, with a focus on gut microbiota interactions. In our study, a dextran sulfate sodium‐induced UC mouse model was used to evaluate AA's therapeutic potential and explore its impact on gut microbiota composition and function. We further used an antibiotic cocktail and fecal microbiota transplantation assays to substantiate the role of gut microbiota in AA's mechanisms of action. A metabolomic analysis was also conducted to identify key metabolic pathways and gut microbiota‐derived metabolites involved in AA's effects. Our findings demonstrated that AA significantly alleviates symptoms of UC, including reducing weight loss, slowing disease progression, mitigating colonic inflammation, and restoring immune balance. Mechanistically, the beneficial effects of AA were strongly linked to alterations in the gut microbiota and its metabolites, particularly γ‐glutamyltyrosine. This metabolite was found to regulate the cyclic adenosine monophosphate/protein kinase A/nuclear factor kappa‐B signaling pathway, which plays a crucial role in inflammatory responses. Overall, these findings strongly suggest that AA holds promise as a therapeutic agent for UC by modulating the gut microbiota and influencing critical inflammatory pathways.

Subjects

MeSH terms (MEDLINE)

Gastrointestinal MicrobiomeColitis, UlcerativePentacyclic TriterpenesTyrosineAnimalsNF-kappa BMiceMaleSignal TransductionCyclic AMPCyclic AMP-Dependent Protein KinasesDisease Models, AnimalDextran SulfateFecal Microbiota TransplantationMice, Inbred C57BLColon

Author keywords

asiatic acidcAMP/PKA/NF‐κB pathwaygut microbiotaulcerative colitisγ‐glutamyltyrosine

Substances

asiatic acidNF-kappa BPentacyclic TriterpenesCyclic AMPCyclic AMP-Dependent Protein KinasesDextran SulfateTyrosine

Authors and institutions

  • Department of Pharmacy, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, China.
  • Department of Pathology, Kunshan Hospital of Traditional Chinese Medicine, Kunshan, China.
  • School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.

ORCID profiles: Baofei Yan

Funding

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • Clinical Pharmaceutical Research Foundation of Jiangsu Hengrui Medicine
  • Clinical Medical Science and Technology Development Foundation of Jiangsu University
  • Science and Technology Project of Kunshan

Cite

APA

Zheng, X., Jiang, Y., Wang, W., Sun, K., Zhou, L., Zhang, Y., Cui, J., Yu, H., Dong, W., & Yan, B. (2026). Asiatic Acid Alleviates Ulcerative Colitis Through a Gut Microbiota‐Driven cAMP / PKA / NF ‐ κB Pathway: γ‐Glutamyltyrosine Is a Crucial Player. Phytotherapy Research, 40(1), 267-285. https://doi.org/10.1002/ptr.70132

Vancouver

Zheng X, Jiang Y, Wang W, Sun K, Zhou L, Zhang Y, et al. Asiatic Acid Alleviates Ulcerative Colitis Through a Gut Microbiota‐Driven cAMP / PKA / NF ‐ κB Pathway: γ‐Glutamyltyrosine Is a Crucial Player. Phytotherapy Research. 2026;40(1):267-285. doi:10.1002/ptr.70132

BibTeX
@article{Zheng2026,
  author = {Zheng, Xian and Jiang, Yuanyue and Wang, Wenbo and Sun, Kekang and Zhou, Libin and Zhang, Yanru and Cui, Jie and Yu, Haiyan and Dong, Wenbin and Yan, Baofei},
  title = {Asiatic Acid Alleviates Ulcerative Colitis Through a Gut Microbiota‐Driven cAMP / PKA / NF ‐ κB Pathway: γ‐Glutamyltyrosine Is a Crucial Player},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {1},
  pages = {267--285},
  doi = {10.1002/ptr.70132}
}
Start for free →